In plain language
In transfemoral transcatheter aortic valve replacement (TAVR), a noise-reduction imaging system and a lower frame rate were each associated with substantially lower patient radiation dose indices. Staff dose was not measured, although lower patient dose usually means less scatter for the fluoroscopy team.
At a glance
- Type of study
- Original research, Retrospective cohort study
- Who was studied
- Patients
- Summary based on
- the abstract
What it found
The noise-reduction technology system was associated with roughly half the patient kerma-area product (KAP) and air kerma of the standard system in transfemoral TAVR.
Key figures: KAP 153 Gy·cm² [interquartile range (IQR), 95-234] vs 78.3 Gy·cm² [IQR, 54.4-103.5]; P<.001; air kerma (AK) at IRP 1.454 Gy vs 0.620 Gy; P<.001
On the standard system, lowering the frame rate from 15 to 7.5 fps reduced patient KAP and air kerma.
Key figures: KAP 184 Gy·cm² vs 106.8 Gy·cm² (P<.01); AK at IRP 0.973 Gy vs 0.64 Gy (P<.01)
The authors conclude that both the low frame-rate protocol and noise-reduction technology markedly reduce patient radiation exposure in TAVR.
Limits to keep in mind
Single-period observational comparison of patient dose indices only, with no staff dose measured. The abstract does not report the number of procedures, the country or adjustment for patient and procedural differences.
Related research summaries
- Fluoroscopy-minimization strategy for catheter ablation of Supraventricular Tachycardia by wOmen OPerators: the STOOP Multicentre Registry (2026, Prospective cohort study)
- Two Central Nervous System Tumors in One Catheter Lab: Time to Rethink Radiation Protection (2026, Retrospective cohort study)
- Radiation Awareness for EVAR in Hybrid Operating Room: An Instant Operator Risk Chart (2021, Dosimetry measurement study)
- Utilization of a Radiation Safety Time-Out Reduces Radiation Exposure During Electrophysiology Procedures (2019, Prospective cohort study)
- Completely nonfluoroscopic catheter ablation of left atrial arrhythmias and ventricular tachycardia (2018, Case report or series)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.